163 related articles for article (PubMed ID: 18209897)
1. [Potential therapeutic approaches for prevention and treatment of diabetic nephropathy and neuropathy: evidences of cilostazol].
Rosa MP; Baroni GV; Portal VL
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1528-32. PubMed ID: 18209897
[TBL] [Abstract][Full Text] [Related]
2. Effect of cilostazol in treating diabetes-associated microvascular complications.
Asal NJ; Wojciak KA
Endocrine; 2017 May; 56(2):240-244. PubMed ID: 28293857
[TBL] [Abstract][Full Text] [Related]
3. Cilostazol: treatment of intermittent claudication.
Reilly MP; Mohler ER
Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol approved for use in intermittent claudication.
Miller JL
Am J Health Syst Pharm; 1999 Mar; 56(5):404. PubMed ID: 10096695
[No Abstract] [Full Text] [Related]
6. Antiplatelet therapy using cilostazol, a specific PDE3 inhibitor.
Ikeda Y
Thromb Haemost; 1999 Aug; 82(2):435-8. PubMed ID: 10605734
[No Abstract] [Full Text] [Related]
7. The role of cilostazol (Pletal) in the management of intermittent claudication.
Bradbury AW
Int J Clin Pract; 2003 Jun; 57(5):405-9. PubMed ID: 12846346
[TBL] [Abstract][Full Text] [Related]
8. Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication.
Smith JA
Clin Cardiol; 2002 Mar; 25(3):91-4. PubMed ID: 11892686
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol in the management of atherosclerosis.
Sallustio F; Rotondo F; Di Legge S; Stanzione P
Curr Vasc Pharmacol; 2010 May; 8(3):363-72. PubMed ID: 20180773
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol in the management of vascular disease.
Dalainas I
Int Angiol; 2007 Mar; 26(1):1-7. PubMed ID: 17353881
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol and peripheral arterial disease.
Pearce L; Ghosh J; Counsell A; Serracino-Inglott F
Expert Opin Pharmacother; 2008 Oct; 9(15):2683-90. PubMed ID: 18803454
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.
Grouse JR; Allan MC; Elam MB
J Clin Pharmacol; 2002 Dec; 42(12):1291-8. PubMed ID: 12463722
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol: a review of its use in intermittent claudication.
Chapman TM; Goa KL
Am J Cardiovasc Drugs; 2003; 3(2):117-38. PubMed ID: 14727939
[TBL] [Abstract][Full Text] [Related]
15. Treating peripheral arterial disease in patients with diabetes.
Hittel N; Donnelly R
Diabetes Obes Metab; 2002 Mar; 4 Suppl 2():S26-31. PubMed ID: 12180355
[TBL] [Abstract][Full Text] [Related]
16. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
[TBL] [Abstract][Full Text] [Related]
17. Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
Naka K; Sasaki H; Kishi Y; Furuta M; Sanke T; Nanjo K; Mukoyama M
Diabetes Res Clin Pract; 1995 Dec; 30(3):153-62. PubMed ID: 8861454
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication.
Thompson PD; Zimet R; Forbes WP; Zhang P
Am J Cardiol; 2002 Dec; 90(12):1314-9. PubMed ID: 12480040
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol.
Sorkin EM; Markham A
Drugs Aging; 1999 Jan; 14(1):63-71; discussion 72-3. PubMed ID: 10069409
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol.
Cheng JW
Heart Dis; 1999; 1(3):182-6. PubMed ID: 11720622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
